Michael Domino
About Michael Domino
Michael Domino is a Manager at Bristol Myers Squibb and a Senior Analyst at Celgene in Phoenix, Arizona, with over a decade of experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Michael Domino currently holds the position of Manager at Bristol Myers Squibb. He commenced this role on October 1, 2019. In this capacity, he leverages his extensive experience in the pharmaceutical industry to oversee various operational functions. His responsibilities include managing projects, leading teams, and ensuring compliance with industry regulations and company policies.
Senior Analyst and Analyst Roles at Celgene
In addition to his managerial role, Michael Domino works at Celgene in two distinct capacities: as a Senior Analyst and as an Analyst in the Phoenix, Arizona Area. His dual roles involve data analysis, reporting, and contributing to the company's strategic initiatives. These positions allow him to utilize and further develop his analytical skills and industry knowledge.
Celgene Experience from Operator to Analyst
Michael Domino began his career at Celgene in 2011 as an Operator, a position he held for four years. During this time, he gained a foundational understanding of the pharmaceutical industry. After his time as an Operator, he transitioned to more analytical roles, eventually becoming an Analyst and a Senior Analyst. His progression within Celgene highlights his ability to adapt and grow within the company.
Educational Background at University of Arizona
Michael Domino earned a Bachelor's Degree in Public Health from the University of Arizona, where he studied from 2005 to 2010. His academic background in public health provides him with a strong foundation in health sciences and public health principles, which are essential in his roles within the pharmaceutical industry.
Experience in the Pharmaceutical Industry
Michael Domino has accumulated over a decade of experience in the pharmaceutical industry. Starting his career at Celgene in 2011, he has held various roles that span operational and analytical responsibilities. His long tenure in the industry reflects his deep understanding of the sector and his ability to contribute effectively to his teams at both Celgene and Bristol Myers Squibb.